TP53 and nasopharyngeal carcinoma: HMF-induced AMPK activation inhibited the growth, invasion, and metastatic potency of NPC cells by downregulating mTOR signaling pathway activation and COX-2 protein levels, as well as enhancing p53 phosphorylation.